Ligand Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc. (LGNXZ) Stock Competitors & Peer Comparison
See (LGNXZ) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LGNXZ | $0.00 | +0.00% | 31.9K | N/A | N/A | N/A |
| ALBBY | $11.15 | +0.00% | 9B | 31.86 | $0.35 | N/A |
| ALBHF | $0.55 | +4.81% | 8.9B | 27.55 | $0.02 | N/A |
| RADLY | $4.63 | +1.76% | 8.1B | 28.94 | $0.16 | +1.62% |
| RGEDF | $43.36 | +2.65% | 7.9B | 10.63 | $4.08 | +3.32% |
| MSMKF | $18.17 | +0.00% | 7.2B | 19.75 | $0.92 | +1.72% |
| DCHPF | $46.90 | -0.21% | 5.3B | -151.29 | -$0.31 | N/A |
| CSMYF | $61.39 | +27.18% | 4.9B | 24.46 | $2.51 | +0.82% |
| GEDSF | $24.85 | +0.00% | 4.5B | 10.71 | $2.32 | +5.89% |
| TSUSF | $17.25 | +0.00% | 4.2B | 41.07 | $0.42 | +6.12% |
Stock Comparison
LGNXZ vs ALBBY Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, ALBBY has a market cap of 9B. Regarding current trading prices, LGNXZ is priced at $0.00, while ALBBY trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas ALBBY's P/E ratio is 31.86. In terms of profitability, LGNXZ's ROE is +0.16%, compared to ALBBY's ROE of +0.13%. Regarding short-term risk, LGNXZ and ALBBY have similar daily volatility (0.00).Check ALBBY's competition here
LGNXZ vs ALBHF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, ALBHF has a market cap of 8.9B. Regarding current trading prices, LGNXZ is priced at $0.00, while ALBHF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas ALBHF's P/E ratio is 27.55. In terms of profitability, LGNXZ's ROE is +0.16%, compared to ALBHF's ROE of +0.13%. Regarding short-term risk, LGNXZ and ALBHF have similar daily volatility (0.00).Check ALBHF's competition here
LGNXZ vs RADLY Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, RADLY has a market cap of 8.1B. Regarding current trading prices, LGNXZ is priced at $0.00, while RADLY trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas RADLY's P/E ratio is 28.94. In terms of profitability, LGNXZ's ROE is +0.16%, compared to RADLY's ROE of +0.19%. Regarding short-term risk, LGNXZ is less volatile compared to RADLY. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check RADLY's competition here
LGNXZ vs RGEDF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, RGEDF has a market cap of 7.9B. Regarding current trading prices, LGNXZ is priced at $0.00, while RGEDF trades at $43.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas RGEDF's P/E ratio is 10.63. In terms of profitability, LGNXZ's ROE is +0.16%, compared to RGEDF's ROE of +0.17%. Regarding short-term risk, LGNXZ is less volatile compared to RGEDF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check RGEDF's competition here
LGNXZ vs MSMKF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, MSMKF has a market cap of 7.2B. Regarding current trading prices, LGNXZ is priced at $0.00, while MSMKF trades at $18.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas MSMKF's P/E ratio is 19.75. In terms of profitability, LGNXZ's ROE is +0.16%, compared to MSMKF's ROE of +0.11%. Regarding short-term risk, LGNXZ and MSMKF have similar daily volatility (0.00).Check MSMKF's competition here
LGNXZ vs DCHPF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, DCHPF has a market cap of 5.3B. Regarding current trading prices, LGNXZ is priced at $0.00, while DCHPF trades at $46.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas DCHPF's P/E ratio is -151.29. In terms of profitability, LGNXZ's ROE is +0.16%, compared to DCHPF's ROE of -0.04%. Regarding short-term risk, LGNXZ and DCHPF have similar daily volatility (0.00).Check DCHPF's competition here
LGNXZ vs CSMYF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, CSMYF has a market cap of 4.9B. Regarding current trading prices, LGNXZ is priced at $0.00, while CSMYF trades at $61.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas CSMYF's P/E ratio is 24.46. In terms of profitability, LGNXZ's ROE is +0.16%, compared to CSMYF's ROE of +0.12%. Regarding short-term risk, LGNXZ and CSMYF have similar daily volatility (0.00).Check CSMYF's competition here
LGNXZ vs GEDSF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, GEDSF has a market cap of 4.5B. Regarding current trading prices, LGNXZ is priced at $0.00, while GEDSF trades at $24.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas GEDSF's P/E ratio is 10.71. In terms of profitability, LGNXZ's ROE is +0.16%, compared to GEDSF's ROE of +0.17%. Regarding short-term risk, LGNXZ and GEDSF have similar daily volatility (0.00).Check GEDSF's competition here
LGNXZ vs TSUSF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, TSUSF has a market cap of 4.2B. Regarding current trading prices, LGNXZ is priced at $0.00, while TSUSF trades at $17.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas TSUSF's P/E ratio is 41.07. In terms of profitability, LGNXZ's ROE is +0.16%, compared to TSUSF's ROE of +0.10%. Regarding short-term risk, LGNXZ and TSUSF have similar daily volatility (0.00).Check TSUSF's competition here
LGNXZ vs CLCGY Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, CLCGY has a market cap of 3.8B. Regarding current trading prices, LGNXZ is priced at $0.00, while CLCGY trades at $32.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas CLCGY's P/E ratio is 19.66. In terms of profitability, LGNXZ's ROE is +0.16%, compared to CLCGY's ROE of +0.49%. Regarding short-term risk, LGNXZ is less volatile compared to CLCGY. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check CLCGY's competition here
LGNXZ vs SGIPF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, SGIPF has a market cap of 3.7B. Regarding current trading prices, LGNXZ is priced at $0.00, while SGIPF trades at $20.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas SGIPF's P/E ratio is 25.19. In terms of profitability, LGNXZ's ROE is +0.16%, compared to SGIPF's ROE of +0.11%. Regarding short-term risk, LGNXZ is less volatile compared to SGIPF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check SGIPF's competition here
LGNXZ vs WLCGF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, WLCGF has a market cap of 3.4B. Regarding current trading prices, LGNXZ is priced at $0.00, while WLCGF trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas WLCGF's P/E ratio is 19.54. In terms of profitability, LGNXZ's ROE is +0.16%, compared to WLCGF's ROE of +0.08%. Regarding short-term risk, LGNXZ and WLCGF have similar daily volatility (0.00).Check WLCGF's competition here
LGNXZ vs SDGCF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, SDGCF has a market cap of 3.3B. Regarding current trading prices, LGNXZ is priced at $0.00, while SDGCF trades at $28.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas SDGCF's P/E ratio is 17.40. In terms of profitability, LGNXZ's ROE is +0.16%, compared to SDGCF's ROE of +0.11%. Regarding short-term risk, LGNXZ and SDGCF have similar daily volatility (0.00).Check SDGCF's competition here
LGNXZ vs HTSUY Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, HTSUY has a market cap of 2.6B. Regarding current trading prices, LGNXZ is priced at $0.00, while HTSUY trades at $9.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas HTSUY's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to HTSUY's ROE of +0.07%. Regarding short-term risk, LGNXZ is less volatile compared to HTSUY. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check HTSUY's competition here
LGNXZ vs ZRSEF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, ZRSEF has a market cap of 1.8B. Regarding current trading prices, LGNXZ is priced at $0.00, while ZRSEF trades at $36.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas ZRSEF's P/E ratio is -6.39. In terms of profitability, LGNXZ's ROE is +0.16%, compared to ZRSEF's ROE of -0.30%. Regarding short-term risk, LGNXZ is less volatile compared to ZRSEF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check ZRSEF's competition here
LGNXZ vs SAEYY Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, SAEYY has a market cap of 943.2M. Regarding current trading prices, LGNXZ is priced at $0.00, while SAEYY trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas SAEYY's P/E ratio is -21.32. In terms of profitability, LGNXZ's ROE is +0.16%, compared to SAEYY's ROE of -0.08%. Regarding short-term risk, LGNXZ and SAEYY have similar daily volatility (0.00).Check SAEYY's competition here
LGNXZ vs SHPPF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, SHPPF has a market cap of 919M. Regarding current trading prices, LGNXZ is priced at $0.00, while SHPPF trades at $45.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas SHPPF's P/E ratio is -20.63. In terms of profitability, LGNXZ's ROE is +0.16%, compared to SHPPF's ROE of -0.08%. Regarding short-term risk, LGNXZ and SHPPF have similar daily volatility (0.00).Check SHPPF's competition here
LGNXZ vs BJTRF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, BJTRF has a market cap of 535.9M. Regarding current trading prices, LGNXZ is priced at $0.00, while BJTRF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas BJTRF's P/E ratio is 8.00. In terms of profitability, LGNXZ's ROE is +0.16%, compared to BJTRF's ROE of +0.02%. Regarding short-term risk, LGNXZ is less volatile compared to BJTRF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check BJTRF's competition here
LGNXZ vs NVACF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, NVACF has a market cap of 78.5M. Regarding current trading prices, LGNXZ is priced at $0.00, while NVACF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas NVACF's P/E ratio is 31.60. In terms of profitability, LGNXZ's ROE is +0.16%, compared to NVACF's ROE of +0.06%. Regarding short-term risk, LGNXZ is less volatile compared to NVACF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check NVACF's competition here
LGNXZ vs MYCOF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, MYCOF has a market cap of 61.8M. Regarding current trading prices, LGNXZ is priced at $0.00, while MYCOF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas MYCOF's P/E ratio is 0.57. In terms of profitability, LGNXZ's ROE is +0.16%, compared to MYCOF's ROE of -0.20%. Regarding short-term risk, LGNXZ and MYCOF have similar daily volatility (0.00).Check MYCOF's competition here
LGNXZ vs HEWA Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, HEWA has a market cap of 6M. Regarding current trading prices, LGNXZ is priced at $0.00, while HEWA trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas HEWA's P/E ratio is -4.67. In terms of profitability, LGNXZ's ROE is +0.16%, compared to HEWA's ROE of -0.08%. Regarding short-term risk, LGNXZ is less volatile compared to HEWA. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check HEWA's competition here
LGNXZ vs FFLWF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, FFLWF has a market cap of 5.4M. Regarding current trading prices, LGNXZ is priced at $0.00, while FFLWF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas FFLWF's P/E ratio is -0.08. In terms of profitability, LGNXZ's ROE is +0.16%, compared to FFLWF's ROE of -0.97%. Regarding short-term risk, LGNXZ is less volatile compared to FFLWF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check FFLWF's competition here
LGNXZ vs PNPL Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, PNPL has a market cap of 4M. Regarding current trading prices, LGNXZ is priced at $0.00, while PNPL trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas PNPL's P/E ratio is -5.51. In terms of profitability, LGNXZ's ROE is +0.16%, compared to PNPL's ROE of +0.10%. Regarding short-term risk, LGNXZ and PNPL have similar daily volatility (0.00).Check PNPL's competition here
LGNXZ vs SYDRF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, SYDRF has a market cap of 2.9M. Regarding current trading prices, LGNXZ is priced at $0.00, while SYDRF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas SYDRF's P/E ratio is 10.00. In terms of profitability, LGNXZ's ROE is +0.16%, compared to SYDRF's ROE of -0.42%. Regarding short-term risk, LGNXZ and SYDRF have similar daily volatility (0.00).Check SYDRF's competition here
LGNXZ vs GABLF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, GABLF has a market cap of 2.7M. Regarding current trading prices, LGNXZ is priced at $0.00, while GABLF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas GABLF's P/E ratio is -0.04. In terms of profitability, LGNXZ's ROE is +0.16%, compared to GABLF's ROE of +2.91%. Regarding short-term risk, LGNXZ and GABLF have similar daily volatility (0.00).Check GABLF's competition here
LGNXZ vs ETBI Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, ETBI has a market cap of 2.1M. Regarding current trading prices, LGNXZ is priced at $0.00, while ETBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas ETBI's P/E ratio is -0.10. In terms of profitability, LGNXZ's ROE is +0.16%, compared to ETBI's ROE of +0.41%. Regarding short-term risk, LGNXZ and ETBI have similar daily volatility (0.00).Check ETBI's competition here
LGNXZ vs RLLVF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, RLLVF has a market cap of 2M. Regarding current trading prices, LGNXZ is priced at $0.00, while RLLVF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas RLLVF's P/E ratio is -0.60. In terms of profitability, LGNXZ's ROE is +0.16%, compared to RLLVF's ROE of +2.21%. Regarding short-term risk, LGNXZ is less volatile compared to RLLVF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check RLLVF's competition here
LGNXZ vs IWINF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, IWINF has a market cap of 1.7M. Regarding current trading prices, LGNXZ is priced at $0.00, while IWINF trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas IWINF's P/E ratio is -0.06. In terms of profitability, LGNXZ's ROE is +0.16%, compared to IWINF's ROE of -0.21%. Regarding short-term risk, LGNXZ and IWINF have similar daily volatility (0.00).Check IWINF's competition here
LGNXZ vs LGNZZ Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, LGNZZ has a market cap of 1.6M. Regarding current trading prices, LGNXZ is priced at $0.00, while LGNZZ trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas LGNZZ's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to LGNZZ's ROE of +0.16%. Regarding short-term risk, LGNXZ and LGNZZ have similar daily volatility (0.00).Check LGNZZ's competition here
LGNXZ vs BIEI Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, BIEI has a market cap of 1.3M. Regarding current trading prices, LGNXZ is priced at $0.00, while BIEI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas BIEI's P/E ratio is -0.13. In terms of profitability, LGNXZ's ROE is +0.16%, compared to BIEI's ROE of +0.03%. Regarding short-term risk, LGNXZ is less volatile compared to BIEI. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check BIEI's competition here
LGNXZ vs NUTTQ Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, NUTTQ has a market cap of 1.1M. Regarding current trading prices, LGNXZ is priced at $0.00, while NUTTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas NUTTQ's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to NUTTQ's ROE of +3.01%. Regarding short-term risk, LGNXZ is less volatile compared to NUTTQ. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check NUTTQ's competition here
LGNXZ vs CAFS Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, CAFS has a market cap of 939.1K. Regarding current trading prices, LGNXZ is priced at $0.00, while CAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas CAFS's P/E ratio is 0.49. In terms of profitability, LGNXZ's ROE is +0.16%, compared to CAFS's ROE of +1.94%. Regarding short-term risk, LGNXZ is less volatile compared to CAFS. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check CAFS's competition here
LGNXZ vs LGNYZ Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, LGNYZ has a market cap of 737.8K. Regarding current trading prices, LGNXZ is priced at $0.00, while LGNYZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas LGNYZ's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to LGNYZ's ROE of +0.16%. Regarding short-term risk, LGNXZ and LGNYZ have similar daily volatility (0.00).Check LGNYZ's competition here
LGNXZ vs CNBI Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, CNBI has a market cap of 686.8K. Regarding current trading prices, LGNXZ is priced at $0.00, while CNBI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas CNBI's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to CNBI's ROE of +0.17%. Regarding short-term risk, LGNXZ is less volatile compared to CNBI. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check CNBI's competition here
LGNXZ vs RADCQ Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, RADCQ has a market cap of 559.7K. Regarding current trading prices, LGNXZ is priced at $0.00, while RADCQ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas RADCQ's P/E ratio is -0.00. In terms of profitability, LGNXZ's ROE is +0.16%, compared to RADCQ's ROE of +3.01%. Regarding short-term risk, LGNXZ is less volatile compared to RADCQ. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check RADCQ's competition here
LGNXZ vs MMDCF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, MMDCF has a market cap of 541.2K. Regarding current trading prices, LGNXZ is priced at $0.00, while MMDCF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas MMDCF's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to MMDCF's ROE of N/A. Regarding short-term risk, LGNXZ and MMDCF have similar daily volatility (0.00).Check MMDCF's competition here
LGNXZ vs AEGY Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, AEGY has a market cap of 411.2K. Regarding current trading prices, LGNXZ is priced at $0.00, while AEGY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas AEGY's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to AEGY's ROE of +0.00%. Regarding short-term risk, LGNXZ and AEGY have similar daily volatility (0.00).Check AEGY's competition here
LGNXZ vs IPAH Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, IPAH has a market cap of 270.8K. Regarding current trading prices, LGNXZ is priced at $0.00, while IPAH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas IPAH's P/E ratio is -0.05. In terms of profitability, LGNXZ's ROE is +0.16%, compared to IPAH's ROE of -0.82%. Regarding short-term risk, LGNXZ is less volatile compared to IPAH. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check IPAH's competition here
LGNXZ vs IMMB Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, IMMB has a market cap of 115K. Regarding current trading prices, LGNXZ is priced at $0.00, while IMMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas IMMB's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to IMMB's ROE of -0.09%. Regarding short-term risk, LGNXZ is less volatile compared to IMMB. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check IMMB's competition here
LGNXZ vs FOGCF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, FOGCF has a market cap of 97.2K. Regarding current trading prices, LGNXZ is priced at $0.00, while FOGCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas FOGCF's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to FOGCF's ROE of +3.99%. Regarding short-term risk, LGNXZ is less volatile compared to FOGCF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check FOGCF's competition here
LGNXZ vs MDIN Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, MDIN has a market cap of 90.3K. Regarding current trading prices, LGNXZ is priced at $0.00, while MDIN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas MDIN's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to MDIN's ROE of +0.36%. Regarding short-term risk, LGNXZ is less volatile compared to MDIN. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check MDIN's competition here
LGNXZ vs OXIHF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, OXIHF has a market cap of 72K. Regarding current trading prices, LGNXZ is priced at $0.00, while OXIHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas OXIHF's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to OXIHF's ROE of +3.30%. Regarding short-term risk, LGNXZ is less volatile compared to OXIHF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check OXIHF's competition here
LGNXZ vs AXMP Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, AXMP has a market cap of 40.9K. Regarding current trading prices, LGNXZ is priced at $0.00, while AXMP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas AXMP's P/E ratio is 0.05. In terms of profitability, LGNXZ's ROE is +0.16%, compared to AXMP's ROE of N/A. Regarding short-term risk, LGNXZ is less volatile compared to AXMP. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check AXMP's competition here
LGNXZ vs DECN Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, DECN has a market cap of 35.5K. Regarding current trading prices, LGNXZ is priced at $0.00, while DECN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas DECN's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to DECN's ROE of -103.89%. Regarding short-term risk, LGNXZ and DECN have similar daily volatility (0.00).Check DECN's competition here
LGNXZ vs HADV Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, HADV has a market cap of 32.2K. Regarding current trading prices, LGNXZ is priced at $0.00, while HADV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas HADV's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to HADV's ROE of +0.42%. Regarding short-term risk, LGNXZ is less volatile compared to HADV. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check HADV's competition here
LGNXZ vs LGNDZ Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, LGNDZ has a market cap of 31.8K. Regarding current trading prices, LGNXZ is priced at $0.00, while LGNDZ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas LGNDZ's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to LGNDZ's ROE of +0.16%. Regarding short-term risk, LGNXZ and LGNDZ have similar daily volatility (0.00).Check LGNDZ's competition here
LGNXZ vs SPPH Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, SPPH has a market cap of 29.4K. Regarding current trading prices, LGNXZ is priced at $0.00, while SPPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas SPPH's P/E ratio is -0.03. In terms of profitability, LGNXZ's ROE is +0.16%, compared to SPPH's ROE of -0.50%. Regarding short-term risk, LGNXZ and SPPH have similar daily volatility (0.00).Check SPPH's competition here
LGNXZ vs OMHE Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, OMHE has a market cap of 29.3K. Regarding current trading prices, LGNXZ is priced at $0.00, while OMHE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas OMHE's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to OMHE's ROE of +0.73%. Regarding short-term risk, LGNXZ is less volatile compared to OMHE. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check OMHE's competition here
LGNXZ vs SCRCQ Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, SCRCQ has a market cap of 14.1K. Regarding current trading prices, LGNXZ is priced at $0.00, while SCRCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas SCRCQ's P/E ratio is -0.01. In terms of profitability, LGNXZ's ROE is +0.16%, compared to SCRCQ's ROE of +1.63%. Regarding short-term risk, LGNXZ and SCRCQ have similar daily volatility (0.00).Check SCRCQ's competition here
LGNXZ vs TSTS Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, TSTS has a market cap of 12.8K. Regarding current trading prices, LGNXZ is priced at $0.00, while TSTS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas TSTS's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to TSTS's ROE of +2.32%. Regarding short-term risk, LGNXZ and TSTS have similar daily volatility (0.00).Check TSTS's competition here
LGNXZ vs IXSBF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, IXSBF has a market cap of 12.6K. Regarding current trading prices, LGNXZ is priced at $0.00, while IXSBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas IXSBF's P/E ratio is -0.01. In terms of profitability, LGNXZ's ROE is +0.16%, compared to IXSBF's ROE of +1.90%. Regarding short-term risk, LGNXZ is less volatile compared to IXSBF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check IXSBF's competition here
LGNXZ vs VIAP Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, VIAP has a market cap of 10.3K. Regarding current trading prices, LGNXZ is priced at $0.00, while VIAP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas VIAP's P/E ratio is -0.05. In terms of profitability, LGNXZ's ROE is +0.16%, compared to VIAP's ROE of +0.65%. Regarding short-term risk, LGNXZ and VIAP have similar daily volatility (0.00).Check VIAP's competition here
LGNXZ vs HTPRF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, HTPRF has a market cap of 8.2K. Regarding current trading prices, LGNXZ is priced at $0.00, while HTPRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas HTPRF's P/E ratio is -0.00. In terms of profitability, LGNXZ's ROE is +0.16%, compared to HTPRF's ROE of +0.09%. Regarding short-term risk, LGNXZ is less volatile compared to HTPRF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check HTPRF's competition here
LGNXZ vs HBOSF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, HBOSF has a market cap of 7.8K. Regarding current trading prices, LGNXZ is priced at $0.00, while HBOSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas HBOSF's P/E ratio is 0.03. In terms of profitability, LGNXZ's ROE is +0.16%, compared to HBOSF's ROE of +6.69%. Regarding short-term risk, LGNXZ and HBOSF have similar daily volatility (0.00).Check HBOSF's competition here
LGNXZ vs WPHM Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, WPHM has a market cap of 7.7K. Regarding current trading prices, LGNXZ is priced at $0.00, while WPHM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas WPHM's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to WPHM's ROE of -1.56%. Regarding short-term risk, LGNXZ and WPHM have similar daily volatility (0.00).Check WPHM's competition here
LGNXZ vs ALST Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, ALST has a market cap of 6.8K. Regarding current trading prices, LGNXZ is priced at $0.00, while ALST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas ALST's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to ALST's ROE of +0.08%. Regarding short-term risk, LGNXZ and ALST have similar daily volatility (0.00).Check ALST's competition here
LGNXZ vs PXYN Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, PXYN has a market cap of 6.3K. Regarding current trading prices, LGNXZ is priced at $0.00, while PXYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas PXYN's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to PXYN's ROE of -0.20%. Regarding short-term risk, LGNXZ is less volatile compared to PXYN. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check PXYN's competition here
LGNXZ vs IYXI Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, IYXI has a market cap of 5.2K. Regarding current trading prices, LGNXZ is priced at $0.00, while IYXI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas IYXI's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to IYXI's ROE of +1.71%. Regarding short-term risk, LGNXZ and IYXI have similar daily volatility (0.00).Check IYXI's competition here
LGNXZ vs RBII Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, RBII has a market cap of 5K. Regarding current trading prices, LGNXZ is priced at $0.00, while RBII trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas RBII's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to RBII's ROE of -0.04%. Regarding short-term risk, LGNXZ is less volatile compared to RBII. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check RBII's competition here
LGNXZ vs CXBS Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, CXBS has a market cap of 2.7K. Regarding current trading prices, LGNXZ is priced at $0.00, while CXBS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas CXBS's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to CXBS's ROE of +0.00%. Regarding short-term risk, LGNXZ and CXBS have similar daily volatility (0.00).Check CXBS's competition here
LGNXZ vs NEWG Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, NEWG has a market cap of 2.3K. Regarding current trading prices, LGNXZ is priced at $0.00, while NEWG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas NEWG's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to NEWG's ROE of +0.40%. Regarding short-term risk, LGNXZ and NEWG have similar daily volatility (0.00).Check NEWG's competition here
LGNXZ vs FSPM Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, FSPM has a market cap of 1.3K. Regarding current trading prices, LGNXZ is priced at $0.00, while FSPM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas FSPM's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to FSPM's ROE of N/A. Regarding short-term risk, LGNXZ and FSPM have similar daily volatility (0.00).Check FSPM's competition here
LGNXZ vs GRPI Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, GRPI has a market cap of 1K. Regarding current trading prices, LGNXZ is priced at $0.00, while GRPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas GRPI's P/E ratio is -0.02. In terms of profitability, LGNXZ's ROE is +0.16%, compared to GRPI's ROE of +0.09%. Regarding short-term risk, LGNXZ and GRPI have similar daily volatility (0.00).Check GRPI's competition here
LGNXZ vs KIARF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, KIARF has a market cap of 442. Regarding current trading prices, LGNXZ is priced at $0.00, while KIARF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas KIARF's P/E ratio is -0.00. In terms of profitability, LGNXZ's ROE is +0.16%, compared to KIARF's ROE of -1.47%. Regarding short-term risk, LGNXZ is less volatile compared to KIARF. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check KIARF's competition here
LGNXZ vs ACGJ Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, ACGJ has a market cap of 324. Regarding current trading prices, LGNXZ is priced at $0.00, while ACGJ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas ACGJ's P/E ratio is -0.00. In terms of profitability, LGNXZ's ROE is +0.16%, compared to ACGJ's ROE of N/A. Regarding short-term risk, LGNXZ and ACGJ have similar daily volatility (0.00).Check ACGJ's competition here
LGNXZ vs MDVLQ Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, MDVLQ has a market cap of 161. Regarding current trading prices, LGNXZ is priced at $0.00, while MDVLQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas MDVLQ's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to MDVLQ's ROE of -2.39%. Regarding short-term risk, LGNXZ is less volatile compared to MDVLQ. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check MDVLQ's competition here
LGNXZ vs ISHI Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, ISHI has a market cap of 5. Regarding current trading prices, LGNXZ is priced at $0.00, while ISHI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas ISHI's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to ISHI's ROE of N/A. Regarding short-term risk, LGNXZ is less volatile compared to ISHI. This indicates potentially lower risk in terms of short-term price fluctuations for LGNXZ.Check ISHI's competition here
LGNXZ vs SYNI Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, SYNI has a market cap of 3. Regarding current trading prices, LGNXZ is priced at $0.00, while SYNI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas SYNI's P/E ratio is -0.00. In terms of profitability, LGNXZ's ROE is +0.16%, compared to SYNI's ROE of N/A. Regarding short-term risk, LGNXZ and SYNI have similar daily volatility (0.00).Check SYNI's competition here
LGNXZ vs GHTI Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, GHTI has a market cap of 0. Regarding current trading prices, LGNXZ is priced at $0.00, while GHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas GHTI's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to GHTI's ROE of N/A. Regarding short-term risk, LGNXZ and GHTI have similar daily volatility (0.00).Check GHTI's competition here
LGNXZ vs MMCWF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, MMCWF has a market cap of 0. Regarding current trading prices, LGNXZ is priced at $0.00, while MMCWF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas MMCWF's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to MMCWF's ROE of N/A. Regarding short-term risk, LGNXZ and MMCWF have similar daily volatility (0.00).Check MMCWF's competition here
LGNXZ vs TFSHF Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, TFSHF has a market cap of 0. Regarding current trading prices, LGNXZ is priced at $0.00, while TFSHF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas TFSHF's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to TFSHF's ROE of N/A. Regarding short-term risk, LGNXZ and TFSHF have similar daily volatility (0.00).Check TFSHF's competition here
LGNXZ vs MDSI Comparison May 2026
LGNXZ plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LGNXZ stands at 31.9K. In comparison, MDSI has a market cap of 0. Regarding current trading prices, LGNXZ is priced at $0.00, while MDSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LGNXZ currently has a P/E ratio of N/A, whereas MDSI's P/E ratio is N/A. In terms of profitability, LGNXZ's ROE is +0.16%, compared to MDSI's ROE of N/A. Regarding short-term risk, LGNXZ and MDSI have similar daily volatility (0.00).Check MDSI's competition here